PR NEWS Logo
Home
PR NewsWire
NewsWire Today
MarketWire
Submit Your Feeds
Business News
•
MarketWire
• Royalty Pharma Announces $761 Million Acquisition of Interest in BG-12 and Fumaderm
Royalty Pharma Announces $761 Million Acquisition of Interest in BG-12 and Fumaderm
Royalty Pharma Announces $761 Million Acquisition of Interest in BG-12 and Fumaderm
Purchase of Interest in Fumapharm Earn-Out Represents Interest in BG-12 and Fumaderm
View More :
http://www.marketwire.com/mw/release.do?id=1652100&sourceType=3
Releted News by marketwire
Plaza Bank Reports Strong First Quarter 2012 Earnings
EverBank Financial Corp Announces Pricing of Initial Public Offering
Royalty Pharma Announces $761 Million Acquisition of Interest in BG-12 and Fumaderm